SG Americas Securities
FOMX

SG Americas Securities’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

SG Americas Securities’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,230
Closed -$136K – 3681
2016
Q4 		$136K Buy
+12,230
New +$115K ﹤0.01% 2649

Other funds holding FOMX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SG Americas Securities's FOMX Position: Q1 2017 in Review

SG Americas Securities sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2017, closing a stake of 12,230 shares — an estimated $136K sold.

SG Americas Securities first reported a position in FOMX in Q4 2016 and held it in 1 quarter. The position peaked at $136K in Q4 2016. 67 funds tracked by Wall St. Rank hold FOMX as of Q1 2017.

  • SG Americas Securities reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2017 after selling out during the quarter.
  • SG Americas Securities sold 12,230 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2017, an estimated $136K.
  • SG Americas Securities first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2016 and held it in 1 quarter.
  • SG Americas Securities's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $136K in Q4 2016.
  • 67 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2017.

Based on SG Americas Securities's 13F filing for Q1 2017, filed 10 May 2017.